2seventy bio Inc. - TSVT Net earnings per share for the last 12 months

2seventy bio, Inc (TSVT) - corporate logo

2seventy bio, Inc. (TSVT) masterfully integrates complex genetic developments into real-world medical practice. This chart of rolling annual EPS growth demonstrates the pace of business recovery, where the value of 59.10 serves as the current metric. The issuer is increasing Abecma sales in a drive toward profitability. The strategy relies on the monetization of its core product and revenue sharing with its partner following the sale of R&D assets.

2seventybio.com (TSVT): Earnings per share for the last twelve months from 02/11/2024 to 02/20/2024

Financial and market metric breakdowns for 2seventy bio, Inc. (TSVT)

Fundamental company valuation:TSVT 2seventy bio
Flagship merchandise of 2seventy bio, Inc

The performance dynamics of 2seventy bio, Inc. (TSVT) are reflected in the 12-month YoY EPS trend. This indicator captures the annual growth rate of earnings per share, neutralizing time lags between quarterly reports. The calculation is based on a rolling comparison of the current TTM figure against the same period last year. Production stability via CMO partners directly impacts this metric, determining operating profitability. Analyzing this chart prevents the purchase of overvalued assets.